The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: A systematic review

International Journal of Obesity

Volumn 39, Issue 11, 2015, Pages 1565-1574

  Penney, N C ^a   Kinross, J ^a   Newton, R C ^a   Purkayastha, S ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; FARNESOID X RECEPTOR; GLUCOSE; INCRETIN; LIPID; RECEPTOR PROTEIN; TGR5 PROTEIN; UNCLASSIFIED DRUG; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; G PROTEIN COUPLED RECEPTOR;

BARIATRIC SURGERY; CARCINOGENESIS; CHOLESTEROL METABOLISM; COMORBIDITY; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; GLUCOSE HOMEOSTASIS; HUMAN; INTESTINE FLORA; LIPID METABOLISM; METABOLIC DISORDER; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY; COMPLICATION; ENDOPLASMIC RETICULUM; HOMEOSTASIS; METABOLIC DISEASES; METABOLISM; OBESITY, MORBID; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; BILE ACIDS AND SALTS; ENDOPLASMIC RETICULUM; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; GLUCOSE; HOMEOSTASIS; HUMANS; INCRETINS; LIPID METABOLISM; METABOLIC DISEASES; OBESITY, MORBID; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84947038691     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.115     Document Type: Review

References (120)

1. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med. 2014; 370: 2002-2013.
2. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013; 101: 50-56.
3. Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA. 2012; 308: 1142-1149.
4. Ashrafian H, Ahmed K, Rowland SP, Patel VM, Gooderham NJ, Holmes E, et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer. 2011; 117: 1788-1799.
5. Cummings BP, Graham JL, Stanhope KL, Chouinard ML, Havel PJ. Maternal ileal interposition surgery confers metabolic improvements to offspring independent of effects on maternal body weight in UCD-T2DM rats. Obes Surg. 2013; 23: 2042-2049.
6. Ashrafian H, Bueter M, Ahmed K, Suliman A, Bloom SR, Darzi A, et al. Metabolic surgery: an evolution through bariatric animal models. Obes Rev. 2010; 11: 907-920.
7. Kohli R, Setchell KD, Kirby M, Myronovych A, Ryan KK, Ibrahim SH, et al A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 2013; 154: 2341-2351.
8. Kohli R, Bradley D, Setchell KD, Eagon JC, Abumrad N, Klein S. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab. 2013; 98: E708-E712.
9. Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) 2009; 17: 1671-1677.
10. Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes (Lond) 2013; 37: 1553-1559.
11. Kohli R, Kirby M, Setchell KD, Jha P, Klustaitis K, Woollett LA, et al. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities. Am J Physiol Gastrointest Liver Physiol. 2010; 299: G652-G660.
12. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012; 153: 3613-3619.
13. Katona BW, Anant S, Covey DF, Stenson WF. Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J Biol Chem. 2009; 284: 3354-3364.
14. Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009; 15: 3329-3340.
15. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999; 284: 1365-1368.
16. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science. 1999; 284: 1362-1365.
17. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, et al A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell. 2000; 6: 517-526.
18. Brendel C, Schoonjans K, Botrugno OA, Treuter E, Auwerx J. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. Mol Endocrinol. 2002; 16: 2065-2076.
19. Zhang M, Chiang JY. Transcriptional regulation of the human sterol 12alphahydroxylase gene (CYP8B1): roles of heaptocyte nuclear factor 4alpha in mediating bile acid repression. J Biol Chem. 2001; 276: 41690-41699.
20. Kir S, Zhang Y, Gerard RD, Kliewer SA, Mangelsdorf DJ. Nuclear receptors HNF4alpha and LRH-1 cooperate in regulating Cyp7a1 in vivo. J Biol Chem. 2012; 287: 41334-41341.
21. Bhutta HY, White W, Liu Y, Rajpal N, Way J, Rajpal D, et al. Effect of roux-en-y gastric bypass surgery on fecal bile acid excretion in normal and diabetic rats. Diabetes. 2013; 62: A520 (abstract 2018P
22. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW, et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-Talk. Gut. 2011; 60: 1214-1223.
23. Ashrafian H, Li JV, Spagou K, Harling L, Masson P, Darzi A, et al. Bariatric surgery modulates circulating and cardiac metabolites. J Proteome Res. 2014; 13: 570-580.
24. Osto E, Doytcheva P, Corteville C, Spliethoff K, Bueter M, Rohrer L, et al. Increased plasma Glucagon Like Peptide-1 improves endothelial dysfunction immediately after Roux-en-Y gastric bypass prior to body weight loss inhibiting the c-Jun N-Terminal Protein Kinase Signaling. Eur Heart J. 2013; 34: 119 (abstract P617
25. Werling M, Vincent RP, Cross GF, Marschall HU, Fandriks L, Lonroth H, et al. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery. Scand J Gastroenterol. 2013; 48: 1257-1264.
26. Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML, Daud NM, et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut. 2014; 63: 891-902.
27. Steinert RE, Peterli R, Keller S, Meyer-Gerspach AC, Drewe J, Peters T, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity (Silver Spring) 2013; 21: E660-E668.
28. Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, et al A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care. 2013; 36: 1859-1864.
29. Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Kakela P, Paakkonen M, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg. 2012; 22: 1473-1480.
30. Jansen PL, van Werven J, Aarts E, Berends F, Janssen I, Stoker J, et al. Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery. Dig Dis. 2011; 29: 48-51.
31. Dirksen C, Jorgensen NB, Bojsen-Moller KN, Kielgast U, Jacobsen SH, Clausen TR, et al. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond) 2013; 37: 1452-1459.
32. Alam M, Agenor KK, Wang G, Reilly D, Vincent R, Alaghband-Zadeh J, et al. Raised plasma bile acids concentrations are related to change of GLP-1 two years after gastric bypass surgery (GBP) in patients with type 2 diabetes. Obesity. 2011; 19: S156 (abstract 499P
33. Myronovych A, Kirby M, Seeley RJ, Kohli R. Sleeve gastrectomy in obese mice results in elevated serum bile acids and reduced hepatic steatosis that correlate with weight loss post surgery. Gastroenterology. 2012; 142: S13 (abstract 50
34. Cummings BP, Bettaieb A, Graham JL, Stanhope KL, Kowala M, Haj FG, et al. Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology. 2012; 153: 3620-3632.
35. Myronovych A, Kirby M, Ryan KK, Zhang W, Jha P, Setchell KD, et al. Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner. Obesity (Silver Spring) 2014; 22: 390-400.
36. Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014; 509: 183-188.
37. Myronovych A, Salazar-Gonzalez RM, Miles L, Ryan KK, Seeley RJ, Kohli R. Short Heterodimer Partner (SHP) is necessary for the improvement in NASH after sleeve gastrectomy in obese mice. Hepatology. 2013; 58: 234A-236A (abstract 54
38. Stefater MA, Sandoval DA, Chambers AP, Wilson-Perez HE, Hofmann SM, Jandacek R, et al. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology. 2011; 141: 939-949 e1-4.
39. Kohli R, Myronovych A, Xanthakos S, Ryan KK, Jenkins T, Salazar-Gonzalez RM, et al. Sleeve gastrectomy in mice and humans results in weight loss independent suppression of hepatic bile acid synthesis. Gastroenterology. 2013; 144: S319-S320 (abstract Sa1849
40. Haluzikova D, Lacinova Z, Kavalkova P, Drapalova J, Krizova J, Bartlova M, et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity (Silver Spring) 2013; 21: 1335-1342.
41. Belgaumkar AP, Vincent RP, Carswell KA, De w T, Mitry RR, Le Roux CW, et al. Bile acid absorption does not change after laparoscopic sleeve gastrectomy. Obes Surg. 2011; 21: 1106 (abstract P199
42. Belgaumkar AP, Vincent RP, Carswell KA, De w T, Mitry RR, Le Roux CW, et al. Plasma bile acid profile is not altered by laparoscopic sleeve gastrectomy. Obes Surg. 2011; 21: 1072 (abstract P78
43. Mencarelli A, Renga B, D'Amore C, Santorelli C, Graziosi L, Bruno A, et al. Dissociation of intestinal and hepatic activities of FXR and LXRalpha supports metabolic effects of terminal ileum interposition in rodents. Diabetes. 2013; 62: 3384-3393.
44. Cummings BP, Bettaieb A, Graham JL, Kim J, Ma F, Shibata N, et al. Bile-Acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCDT2DM rats. Dis Model Mech. 2013; 6: 443-456.
45. Cummings BP, Strader AD, Stanhope KL, Graham JL, Lee J, Raybould HE, et al. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology. 2010; 138: 2437-46, 2446 e1.
46. Habegger KM, Al-Massadi O, Heppner KM, Myronovych A, Holland J, Berger J, et al. Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut. 2014; 63: 1238-1246.
47. Cohen DE. Balancing cholesterol synthesis and absorption in the gastrointestinal tract. J Clin Lipidol. 2008; 2: S1-S3.
48. West KL, Zern TL, Butteiger DN, Keller BT, Fernandez ML. SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs. Atherosclerosis. 2003; 171: 201-210.
49. Li Q, Chen L, Yang Z, Ye Z, Huang Y, He M, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass indexo35 kg/m2. Diabetes Obes Metab. 2012; 14: 262-270.
50. Corradini SG, Eramo A, Lubrano C, Spera G, Cornoldi A, Grossi A, et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg. 2005; 15: 367-377.
51. Heffron SP, Singh A, Zagzag J, Youn HA, Underberg JA, Fielding GA, et al. Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30-40 kg/m (2.). Atherosclerosis. 2014; 237: 183-190.
52. Milone M, Lupoli R, Maietta P, Di Minno A, Bianco P, Ambrosino P, et al. Lipid profile changes in patients undergoing bariatric surgery: A comparative study between sleeve gastrectomy and mini-gastric bypass. Int J Surg. 2015; 14: 28-32.
53. Griffo E, Nosso G, Lupoli R, Cotugno M, Saldalamacchia G, Vitolo G, et al. Early improvement of postprandial lipemia after bariatric surgery in obese type 2 diabetic patients. Obes Surg. 2014; 24: 765-770.
54. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 2000; 14: 2819-2830.
55. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J. 2006; 25: 1419-1425.
56. Prieur X, Coste H, Rodriguez JC. The human apolipoprotein AV gene is regulated by peroxisome proliferator-Activated receptor-Alpha and contains a novel farnesoid X-Activated receptor response element. J Biol Chem. 2003; 278: 25468-25480.
57. Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, et al. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology. 2003; 125: 544-555.
58. Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Bile acids induce the expression of the human peroxisome proliferator-Activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol. 2003; 17: 259-272.
59. Lee J, Seok S, Yu P, Kim K, Smith Z, Rivas-Astroza M, et al. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology. 2012; 56: 108-117.
60. Heni M, Wagner R, Ketterer C, Bohm A, Linder K, Machicao F, et al. Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans. J Clin Endocrinol Metab. 2013; 98: E1224-E1229.
61. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987; 2: 1300-1304.
62. Yabe D, Seino Y. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and beta cell preservation. Prog Biophys Mol Biol. 2011; 107: 248-256.
63. Parker HE, Wallis K, le Roux CW, Wong KY, Reimann F, Gribble FM. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br J Pharmacol. 2012; 165: 414-423.
64. Adrian TE, Gariballa S, Parekh KA, Thomas SA, Saadi H, Al Kaabi J, et al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia. 2012; 55: 2343-2347.
65. Van der Schueren BJ, Homel P, Alam M, Agenor K, Wang G, Reilly D, et al. Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery. Diabetes Care. 2012; 35: 42-46.
66. Salehi M, Prigeon RL, D'Alessio DA. Gastric bypass surgery enhances glucagonlike peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011; 60: 2308-2314.
67. Alam ML, Van der Schueren BJ, Ahren B, Wang GC, Swerdlow NJ, Arias S, et al. Gastric bypass surgery, but not caloric restriction, De creases dipeptidyl peptidase-4 activity in obese patients with type 2 diabetes. Diabetes Obes Metab. 2011; 13: 378-381.
68. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009; 58: 1400-1407.
69. Fu L, John LM, Adams SH, Yu XX, Tomlinson E, Renz M, et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology. 2004; 145: 2594-2603.
70. Jimenez A, Casamitjana R, Viaplana-Masclans J, Lacy A, Vidal J. GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care. 2013; 36: 2062-2069.
71. Sato M, Shibata C, Kikuchi D, Ikezawa F, Imoto H, Sasaki I. Effects of biliary and pancreatic juice diversion into the ileum on gastrointestinal motility and gut hormone secretion in conscious dogs. Surgery. 2010; 148: 1012-1019.
72. Ullmer C, Alvarez Sanchez R, Sprecher U, Raab S, Mattei P, De hmlow H, et al. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release. Br J Pharmacol. 2013; 169: 671-684.
73. Wu T, Bound MJ, Standfield SD, Gedulin B, Jones KL, Horowitz M, et al. Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. Diabetes Obes Metab. 2013; 15: 474-477.
74. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007; 246: 780-785.
75. Koop I, Schindler M, Bosshammer A, Scheibner J, Stange E, Koop H. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids. Gut. 1996; 39: 661-667.
76. Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2011; 7: 683-690.
77. Keitel V, Gorg B, Bidmon HJ, Zemtsova I, Spomer L, Zilles K, et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia. 2010; 58: 1794-1805.
78. Ryan KK, Kohli R, Gutierrez-Aguilar R, Gaitonde SG, Woods SC, Seeley RJ. Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats. Endocrinology. 2013; 154: 9-15.
79. Morton GJ, Matsen ME, Bracy DP, Meek TH, Nguyen HT, Stefanovski D, et al. FGF19 action in the brain induces insulin-independent glucose lowering. J Clin Invest. 2013; 123: 4799-4808.
80. Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR, et al. Gastric bypass increases energy expenditure in rats. Gastroenterology. 2010; 138: 1845-1853.
81. Nestoridi E, Kvas S, Kucharczyk J, Stylopoulos N. Resting energy expenditure and energetic cost of feeding are augmented after Roux-en-Y gastric bypass in obese mice. Endocrinology. 2012; 153: 2234-2244.
82. Faria SL, Faria OP, Cardeal Mde A, Ito MK, Buffington C. Diet-induced thermogenesis and respiratory quotient after Roux-en-Y gastric bypass surgery: a prospective study. Surg Obes Relat Dis. 2014; 10: 138-143.
83. Schmidt JBS, Gregersen NTG, Pedersen SP, Nielsen MSN, Nielsen LVN, Holst JJH, et al. The effect of Roux-en-Y gastric bypass surgery on energy expenditure and Appetite: A Randomized Human Study including Pair fed control subjects. Obesity Facts. 2013; 6: 28 (abstract T5: OS1.5
84. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006; 439: 484-489.
85. Zhang JH, Nolan JD, Kennie SL, Johnston IM, De w T, Dixon PH, et al. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am J Physiol Gastrointest Liver Physiol. 2013; 304: G940-G948.
86. Tomlinson E, Fu L, John L, Hultgren B, Huang X, Renz M, et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology. 2002; 143: 1741-1747.
87. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006; 313: 1137-1140.
88. Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol. 2011; 19: 349-359.
89. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027-1031.
90. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005; 102: 11070-11075.
91. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-1023.
92. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18: 190-195.
93. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013; 500: 541-546.
94. Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013; 500: 585-588.
95. Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011; 141: 1773-1781.
96. Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol. 2013; 58: 949-955.
97. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013; 341: 1241214.
98. Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143: 913-6 e7.
99. Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013; 98: 16-24.
100. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010; 59: 3049-3057.
101. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009; 106: 2365-2370.
102. Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013; 5: 178ra41.
103. Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A, et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut. 2012; 61: 1124-1131.
104. MacHado AD, Forster-Fromme K, Mitra S, Friedrich A, Kramer K, Huson DH, et al. Competence network obesity: An integrated multi -omics approach to study the guest-host metabolic interaction during restrictive obesity intervention. Obesity Facts. 2012; 5: 4-5 (abstract FV 2.5
105. Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A. 2008; 105: 13580-13585.
106. Miyata M, Yamakawa H, Hamatsu M, Kuribayashi H, Takamatsu Y, Yamazoe Y. Enterobacteria modulate intestinal bile acid transport and homeostasis through apical sodium-dependent bile acid transporter (SLC10A2) expression. J Pharmacol Exp Ther. 2011; 336: 188-196.
107. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA. 2011; 108: 4523-4530.
108. Midtvedt T, Norman A, Nygaard K. Bile acid transforming micro-organisms in rats with an intestinal blind segment. Acta Pathol Microbiol Scand. 1969; 77: 162-166.
109. Kuribayashi H, Miyata M, Yamakawa H, Yoshinari K, Yamazoe Y. Enterobacteriamediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling. Eur J Pharmacol. 2012; 697: 132-138.
110. Ostlund MP, Lu Y, Lagergren J. Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg. 2010; 252: 972-976.
111. Li JV, Reshat R, Wu Q, Ashrafian H, Bueter M, le Roux CW, et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011; 2: 183.
112. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008; 60: 131-144.
113. Kanamoto R, Azuma N, Suda H, Saeki T, Tsuchihashi Y, Iwami K. Elimination of Na +-dependent bile acid transporter from small intestine by ileum resection increases [correction of increase] colonic tumorigenesis in the rat fed deoxycholic acid. Cancer Lett. 1999; 145: 115-120.
114. Houghton PW, Owen RJ, Henly PJ, Mortensen NJ, Hill MJ, Williamson RC. Experimental colonic carcinogenesis after gastric surgery. Br J Surg. 1990; 77: 774-778.
115. Adami GF, Papadia FS, Marinari GM, Camerini GB, Scopinaro N. Does biliopancreatic diversion carry increased risk for colorectal cancer?. A cohort study. Obes Surg. 2008; 18: 212-215.
116. Mahawar KK, Carr WR, Balupuri S, Small PK. Controversy surrounding 'mini gastric bypass. Obes Surg. 2014; 24: 324-333.
117. Musella M, Milone M. Still controversies about the mini gastric bypass?. Obes Surg. 2014; 24: 643-644.
118. Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 2008; 68: 9589-9594.
119. Giordano C, Catalano S, Panza S, Vizza D, Barone I, Bonofiglio D, et al. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression. Oncogene. 2011; 30: 4129-4140.
120. Goldberg AA, Titorenko VI, Beach A, Sanderson JT. Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells. PeerJ. 2013; 1: e122.